USA Domestic Delivery,Canada Domestic Delivery,European Domestic Delivery

Norethisterone enanthate Powder (3836-23-5)

Rating: SKU: 3836-23-5. Category:

AASraw is with synthesis and production ability from gram to mass order of Norethisterone enanthate Powder (3836-23-5), under CGMP regulation and trackable quality control system.

Product Description

 

Norethisterone enanthate Powder (3836-23-5) video

 

 


 

Norethisterone enanthate Powder (3836-23-5) Specification:

Chemical Structure: Product Name: Norethisterone enanthate(NETE)
Cas No.: 3836-23-5
Molecular Formula: C27H38O3
Molecular Weight: 410.58882
Standard: In-house
Storage: Store at room temperature away from light and moisture.
Documents(COA & HPLC etc.): Available

 

Norethisterone enanthate Powder (3836-23-5) Description:

Norethisterone was patented in 1951 and came into medical use in 1957.[7][8] It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system.

Norethisterone enanthate (NETE), also known as norethindrone enanthate, is a form of progestogen-only injectable birth control which is used to prevent pregnancy in women.It may be used following childbirth, miscarriage, or abortion.

Norethisterone enanthate is a synthetic oral progestin hormone with actions similar to those of progesterone but functioning as a more potent inhibitor of ovulation. It is used for contraception or to treat such conditions as secondary amenorrhea, abnormal uterine bleeding, and endometriosis. It is initially hydrolyzed by esterase, resulting in Norethisterone, which diffuses freely into target cells and bind to the progesterone receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary.

 

Reference:

  • Nishino, Y.; Neumann, F. Estrogenic partial effect of gestagens, in particular norethisterone enanthate. Arzneimittel-Forschung. (1980) 30(3): 439-52.
  • Benagiano, G.; Primiero, F. M. Norethindrone enanthate. Advances in Human Fertility and Reproductive Endocrinology. (1983) 2(Long-Acting Steroid Contracept.): 31-64.
  • Garza-Flores, Josue. Pharmacokinetics of once-a-month injectable contraceptives. Contraception. (1994) 49(4): 347-59.

 

 

PRECAUTION AND DISCLAIMER:

This Material is Sold For Research Use Only. Terms of Sale Apply. Not for Human Consumption, nor Medical, Veterinary, or Household Uses.

 


COA

HNMR

References & product citations